BioWorld MedTech

July 8, 2013

An Advance Worth Drinking To: Functional, if still tiny, human liver created from stem cells

Starting with induced pluripotent stem cells (iPSCs), scientists have created the first artificial organ – a functional liver bud, which is the precursor to the mature liver that is normally formed early in embryonic development. Read More

TMS seeks to improve monitoring in ICU via variability analysis

Researchers develop telescope-like contact lens for AMD patients

Washington roundup: AMA urges obesity-as-disease approach; BMI as Dx an issue

Financings roundup: GI Dynamics completes its $57.5M private placement

International report: Guided Therapeutics to place LuViva in Turkey

Agreements/contracts: OptiNose to deliver Avanir's sumatriptan

HIT roundup: Washington hospital launches WeCare EHR system from Epic

Court report: Baxano reaches final agreement with DoJ regarding subpoena

Holiday Notice

Product Briefs

Med-Tech Notes

People in the News

MDD's Neurology Extra

MDD's Financial Roundup (Q213) Deals roundup: Device firms report/close 15 deals in 2Q13 worth $29B

Financings roundup: Second quarter sees drop off compared to first part of 2013

Washington roundup: SCOTUS says no to isolated DNA, but cDNA still eligible

Agreements/contracts: Numbers drop a little; but innovation, and coverage, continues

Today's news in brief

BioWorld

BioWorld briefs for July 10, 2026.

3D rendering of an antibody drug conjugate

‘Target-high but uptake-defective’ state identified in ADC resistance

BioWorld

Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...

Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

BioWorld

News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...

FENS 2026: Shedding light on the sheddome

BioWorld

At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...

FENS 2026: Next-gen biologics take on brain disease

BioWorld

Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...